AssetMark Inc
PMVP icon

AssetMark Inc’s PMV Pharmaceuticals PMVP Stock Holding History

AssetMark Inc’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,220
Closed -$13.6K – 1978
2023
Q3 		$13.6K Buy
2,220
+322
+17% +$2.21K ﹤0.01% 1292
2023
Q2 		$11.9K Buy
1,898
+458
+32% +$2.4K ﹤0.01% 1276
2023
Q1 		$6.87K Buy
1,440
+385
+36% +$2.71K ﹤0.01% 1291
2022
Q4 		$9.18K Buy
1,055
+284
+37% +$3.03K ﹤0.01% 1306
2022
Q3 		$9K Buy
771
+243
+46% +$3.51K ﹤0.01% 1238
2022
Q2 		$8K Buy
528
+267
+102% +$3.89K ﹤0.01% 1246
2022
Q1 		$5K Buy
+261
New +$4.6K ﹤0.01% 1284

Other funds holding PMVP

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

AssetMark Inc's PMVP Position: Q4 2023 in Review

AssetMark Inc sold out of PMV Pharmaceuticals (PMVP) in Q4 2023, closing a stake of 2,220 shares — an estimated $13.6K sold.

AssetMark Inc first reported a position in PMVP in Q1 2022 and held it in 7 quarters. The position peaked at $13.6K in Q3 2023. 98 funds tracked by Wall St. Rank hold PMVP as of Q4 2023.

  • AssetMark Inc reported no remaining PMV Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • AssetMark Inc sold 2,220 PMV Pharmaceuticals shares in Q4 2023, an estimated $13.6K.
  • AssetMark Inc first reported a position in PMV Pharmaceuticals in Q1 2022 and held it in 7 quarters.
  • AssetMark Inc's PMV Pharmaceuticals position peaked at $13.6K in Q3 2023.
  • 98 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q4 2023.

Based on AssetMark Inc's 13F filing for Q4 2023, filed 9 Feb 2024.